首页> 外文期刊>BMC Health Services Research >Barriers and facilitators to pre-exposure prophylaxis (PrEP) eligibility screening and ongoing HIV testing among target populations in Bondo and Rarieda, Kenya: Results of a consultation with community stakeholders
【24h】

Barriers and facilitators to pre-exposure prophylaxis (PrEP) eligibility screening and ongoing HIV testing among target populations in Bondo and Rarieda, Kenya: Results of a consultation with community stakeholders

机译:在肯尼亚邦多和拉里达的目标人群中进行暴露前预防(PrEP)资格筛查和正在进行的艾滋病毒检测的障碍和促进者:与社区利益相关者进行磋商的结果

获取原文
           

摘要

Background As pre-exposure prophylaxis (PrEP) moves closer to availability in developing countries, practical considerations for implementation become important. We conducted a consultation with district-level community stakeholders experienced in HIV-prevention interventions with at-risk populations in Bondo and Rarieda, Kenya to generate locally grounded approaches to the future rollout of oral PrEP to four populations: fishermen, widows, female sex workers, and serodiscordant couples. Methods The 20 consultation participants represented the Ministry of Health, faith- and community-based organizations, health facilities, community groups, and nongovernmental organizations. Participants divided into breakout groups and followed a structured discussion guide asking them to identify barriers to implementing HIV-prevention interventions (including PrEP) with each population. Questions also solicited solutions for addressing these barriers, as well as other facilitators for PrEP implementation. In particular, questions focused on how to encourage people to screen for PrEP eligibility by having HIV and other blood tests and how to encourage compliance with ongoing HIV testing. Results The barriers and facilitators/solutions discussants provided were frequently population-specific, but there were also broad-level similarities across populations. Service delivery barriers to HIV-prevention interventions concerned the need for staff trained to address the needs of particular populations. Service delivery facilitators to provision of ongoing HIV testing consisted of offering testing options besides facility-based testing. Stigma was the main community-level barrier for all groups, whereas barriers at the level of target populations included mobility; lifestyle and life circumstances, especially cultural norms among fishermen and widows; and fears, lack of awareness, and misinformation. Proposed facilitators and strategies for addressing community- and population-level barriers included topic-specific education within the populations and community, involvement of partners and family members, mass HIV testing, and peer educators. Barriers to PrEP uptake included non-adherence to pill taking and missing clinic visits. For drug adherence, facilitators were counselling and involving family members. Discussants suggested that client reminders, e.g., home visits, were needed to encourage clients to keep their clinic appointments. Conclusions Strategies for encouraging eligibility screening and ongoing HIV testing will have local and population-specific aspects. Our results nonetheless apply to similar populations throughout sub-Saharan Africa and reach beyond oral PrEP to other ARV-based PrEP formulations.
机译:背景技术随着暴露前预防(PrEP)越来越接近发展中国家的可用性,实施的实际考虑因素变得很重要。我们与在肯尼亚邦多和拉里达的高危人群进行过艾滋病毒预防干预措施的经验丰富的地区级社区利益相关者进行了磋商,以针对将来针对四个人群(渔民,寡妇,女性性工作者)的口服PrEP推广产生本地化方法和浆糊状的夫妇。方法20名咨询参与者代表了卫生部,基于信仰和社区的组织,卫生机构,社区团体和非政府组织。参加者分为小组,遵循结构化的讨论指南,要求他们确定在每个人群中实施艾滋病毒预防措施(包括PrEP)的障碍。问题还征求了解决这些障碍的解决方案,以及其他实施PrEP的促进者。尤其是,问题集中在如何通过进行HIV和其他血液检测来鼓励人们筛查PrEP资格以及如何鼓励对正在进行的HIV检测的遵守。结果讨论者提供的障碍和促进者/解决方案通常是针对特定人群的,但是在人群之间也存在广泛的相似性。预防艾滋病毒干预措施的服务提供障碍涉及需要培训工作人员以满足特定人群需求的人员。提供正在进行的HIV检测的服务提供者包括提供基于设施的检测之外的检测选项。耻辱感是所有群体在社区一级的主要障碍,而目标人群层面的障碍包括流动性。生活方式和生活环境,尤其是渔民和寡妇的文化规范;和恐惧,缺乏意识以及错误信息。为解决社区和人口一级的障碍而提议的促进者和策略包括在人口和社区中进行主题特定的教育,合作伙伴和家庭成员的参与,大规模的艾滋病毒检测以及同伴教育者。摄取PrEP的障碍包括不坚持服药和缺少门诊服务。对于药物依从性,协调员进行了辅导并让家人参与。讨论者建议需要客户提醒,例如家访,以鼓励客户保持诊所预约。结论鼓励进行资格筛查和持续进行HIV检测的策略将涉及本地和针对特定人群的方面。然而,我们的结果适用于整个撒哈拉以南非洲地区的类似人群,并且不仅限于口服PrEP,还涉及其他基于ARV的PrEP制剂。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号